Cannabis Related Content
CBD oil for pain: What the research shows
Oils by Simpson of 2012 supplies organic full-spectrum CBD cannabis oil products. CBD oil is popular and commonly used for its potent therapeutic benefits, but what about its effect on pain? Here’s what the research shows.
Will 2021 see the UK’s cannabis industry bloom?
John Binns & David Hardstaff from BCL Solicitors LLP, reveal if 2021 will be the year that sees the UK’s cannabis industry bloom.
CBD oil for ADHD: What the research shows
CBD oil is popular for its wide-ranging therapeutic benefits, but what about its effects on ADHD? Here’s what the research shows.
Cannabis as a treatment for COVID-19
Kevin William Simpson, CEO and Founder of OilsBySimpson, tells us about the growing evidence around cannabis as a treatment for COVID-19.
CBD Novel Foods in the UK
Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.
Cannabidiol, skin homeostasis and acne
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.
The UK’s legalisation of medicinal cannabis
David Hardstaff of BCL’s Cannabis Law & Regulatory team considers the success of the UK’s legalisation of medicinal cannabis products.
Medical cannabis in the UK and the industry’s future
Rick Brar, CEO & Chairman of Brains Bioceutical Corp. explores the landscape of medical cannabis in the UK and the future direction of the industry.
Kim Schleppegrell Skaue joins Oils By Simpson: Their mission to promote natural medicine
Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.
Functionality of Hemp Proteins and their Peptides
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains why hemp protein is gaining a reputation as nutraceutical product.
Innovative Pioneers of the Hemp Trade
Elixinol, Merges Water-Soluble Technology with THC-Free CBD in a New Range of CBD Blended Tinctures.
The use of medical cannabis in the UK
Andreas Met, COO, Compliance and Director at Halo Labs highlights how the use of medical cannabis is on the rise in the UK and could offer relief to many NHS patients.
A medical professional’s opinion on medical marijuana
Dr Charlie Easmon from Your Excellent Health Service gives a medical professional’s opinion on medical marijuana in the UK, including comment on hemp, CBD and THC.
The priorities for cannabis research
Here, Robin Emerson, Head of CSR at Brains Bioceutical charts the priorities for cannabis research.
The UK’s clinicians need training in medical cannabis – here’s why
Professor Mike Barnes, Co-Founder of Maple Tree Consultancy states that the UK’s clinicians need training in medical cannabis and explains precisely why this should be.
Can the UK’s post-COVID-19 economy benefit from a booming medical cannabis industry?
Hannah Deacon, Co-Founder of Maple Tree Consultancy and Campaigner ponders if the UK’s post-COVID-19 economy can benefit from a booming medical cannabis industry.
Research finds cannabis could reduce OCD symptoms by 50%
OCD symptoms could be eased by atleast half in the short-term, according to a new study published in the Journal of Affective Disorders.
CBG: The mother of all Cannabinoids with broad antibacterial activity
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains CBG (cannabigerol), a “new” cannabinoid with vast potential in cannabis research.
Savage Cabbage: Where did it begin?
In early 2016, I had reached a point in life where I needed to make a life-changing decision: Read the Savage Cabbage journey on OAG.
EUMCA: Medical cannabis and research collaboration after Brexit
Here, we talk to Professor Trevor Jones at the European Medical Cannabis Association (EUMCA) about storing CBD, clinical trials post-Brexit and the UK-US trade deal.
